:::

詳目顯示

回上一頁
題名:新冠肺炎疫苗發展
書刊名:醫療品質雜誌
作者:林芳如陳志榮
作者(外文):Lin, Fang-juChen, Chih-jung
出版日期:2021
卷期:15:4
頁次:頁78-82
主題關鍵詞:新冠肺炎疫苗
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:4
期刊論文
1.Agrawal, A. S.、Tao, X.、Algaissi, A.(2016)。Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus。Hum Vaccin Immunother.,12(9),2351-2356。  new window
2.Lee, W. S.、Wheatley, A. K.、Kent, S. J.、DeKosky, B. J.(2020)。Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies。Nat Microbiol.,5(10),1185-1191。  new window
3.Polack, F. P.(2007)。Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple。Pediatr Res.,62(1),111-115。  new window
4.Kim, H. W.、Canchola, J. G.、Brandt, C. D.(1969)。Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine。Am J Epidemiol.,89(4),422-434。  new window
5.Fulginiti, V. A.、Eller, J. J.、Downie, A. W.、Kempe, C. H.(1967)。Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines。JAMA,202(12),1075-1080。  new window
6.Osterholm, M. T.、Kelley, N. S.、Sommer, A.、Belongia, E. A.(2012)。Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis。Lancet Infect Dis.,12(1),36-44。  new window
7.Tseng, C. T.、Sbrana, E.、Iwata-Yoshikawa, N.(2012)。Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus。PLoS One,7(4)。  new window
8.Tian, J. H.、Patel, N.、Haupt, R.(2021)。SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice。Nat Commun.,12(1)。  new window
9.Tande, A. J.、Pollock, B. D.、Shah, N. D.(2021)。Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening。Clin Infect Dis.,74(1),59-65。  new window
10.Davies, N. G.、Abbott, S.、Barnard, R. C.(2021)。Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England。Science,372(6538)。  new window
11.Connors, M.、Graham, B. S.、Lane, H. C.、Fauci, A. S.(2021)。SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn。Ann Intern Med.,174(5),687-690。  new window
12.Castilla, J.、Godoy, P.、Domínguez, A.(2013)。Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza。Clin Infect Dis.,57(2),167-175。  new window
13.Zhou, D.、Dejnirattisai, W.、Supasa, P.(2021)。Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera。Cell,184(9),2348-2361.e6。  new window
14.Greinacher, A.、Thiele, T.、Warkentin, T. E.、Weisser, K.、Kyrle, P. A.、Eichinger, S.(2021)。Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination。N Engl J Med.,384,2092-2101。  new window
15.Scully, M.、Singh, D.、Lown, R.(2021)。Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination。N Engl J Med.,384,2202-2211。  new window
16.Schultz, N. H.、Sørvoll, I. H.、Michelsen, A. E.(2021)。Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination。N Engl J Med.,384,2124-2130。  new window
單篇論文
1.Cai, Y.,Zhang, J.,Xiao, T.(2020)。Distinct conformational states of SARS-CoV-2 spike protein。  new window
2.Wu, K.,Werner, A. P.,Moliva, J. I.(2021)。mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants。  new window
3.Wibmer, C. K.,Ayres, F.,Hermanus, T.(2021)。SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma。  new window
其他
1.(2021)。Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults,https://clinicaltrials.gov/ct2/show/NCT04785144。  new window
2.Our World in Data。Coronavirus (COVID-19) Vaccinations,https://ourworldindata.org/covid-vaccinations。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關博士論文
 
無相關書籍
 
無相關著作
 
QR Code
QRCODE